Depression and risk of epithelial ovarian cancer: Results from two large prospective cohort studies

Gynecologic Oncology

Volumn 139, Issue 3, 2015, Pages 481-486

  Huang, Tianyi ^a,b   Poole, Elizabeth M ^a   Okereke, Olivia I ^a,b,c   Kubzansky, Laura D ^b   Eliassen, A Heather ^a,b   Sood, Anil K ^d   Wang, Molin ^a,b   Tworoger, Shelley S ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chronic stress; Depression; Etiology; Latency period; Ovarian cancer; Repeated measures

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; DEPRESSION; DISEASE SEVERITY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; UNITED STATES; ADULT; DISEASE COURSE; FOLLOW UP; HEALTH SURVEY; INCIDENCE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGY; TIME FACTOR;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84949654526     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.10.004     Document Type: Article

References (40)

1. S. Moussavi, S. Chatterji, E. Verdes, A. Tandon, V. Patel, and B. Ustun Depression, chronic diseases, and decrements in health: results from the World Health Surveys Lancet 370 2007 851 858
2. M.B. Howren, D.M. Lamkin, and J. Suls Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis Psychosom. Med. 71 2009 171 186
3. F.S. Luppino, L.M. de Wit, P.F. Bouvy, T. Stijnen, P. Cuijpers, B.W. Penninx, and et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies Arch. Gen. Psychiatry 67 2010 220 229
4. B.W. Penninx, J.M. Guralnik, M. Pahor, L. Ferrucci, J.R. Cerhan, R.B. Wallace, and et al. Chronically depressed mood and cancer risk in older persons J. Natl. Cancer Inst. 90 1998 1888 1893
5. A.L. Gross, J.J. Gallo, and W.W. Eaton Depression and cancer risk: 24 years of follow-up of the Baltimore Epidemiologic Catchment Area sample Cancer Causes Control 21 2010 191 199
6. C.H. Kroenke, G.G. Bennett, C. Fuchs, E. Giovannucci, I. Kawachi, E. Schernhammer, and et al. Depressive symptoms and prospective incidence of colorectal cancer in women Am. J. Epidemiol. 162 2005 839 848
7. G.A. Kaplan, and P. Reynolds Depression and cancer mortality and morbidity: prospective evidence from the Alameda County study J. Behav. Med. 11 1988 1 13
8. R.C. Hahn, and D.B. Petitti Minnesota Multiphasic Personality Inventory-rated depression and the incidence of breast cancer Cancer 61 1988 845 848
9. A.B. Zonderman, P.T. Costa Jr., and R.R. McCrae Depression as a risk for cancer morbidity and mortality in a nationally representative sample JAMA 262 1989 1191 1195
10. S.O. Dalton, L. Mellemkjaer, J.H. Olsen, P.B. Mortensen, and C. Johansen Depression and cancer risk: a register-based study of patients hospitalized with affective disorders, Denmark, 1969-1993 Am. J. Epidemiol. 155 2002 1088 1095
11. C. Lemogne, S.M. Consoli, M. Melchior, H. Nabi, M. Coeuret-Pellicer, F. Limosin, and et al. Depression and the risk of cancer: a 15-year follow-up study of the GAZEL cohort Am. J. Epidemiol. 178 2013 1712 1720
12. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J. Clin. 2015;65:5-29.
13. A.K. Sood, R. Bhatty, A.A. Kamat, C.N. Landen, L. Han, P.H. Thaker, and et al. Stress hormone-mediated invasion of ovarian cancer cells Clin. Cancer Res. 12 2006 369 375
14. P.H. Thaker, L.Y. Han, A.A. Kamat, J.M. Arevalo, R. Takahashi, C. Lu, and et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma Nat. Med. 12 2006 939 944
15. S.K. Lutgendorf, A.Z. Weinrib, F. Penedo, D. Russell, K. DeGeest, E.S. Costanzo, and et al. Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients J. Clin. Oncol. 26 2008 4820 4827
16. B. Davidson, I. Goldberg, W.H. Gotlieb, J. Kopolovic, G. Ben-Baruch, J.M. Nesland, and et al. High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma Clin. Exp. Metastasis 17 1999 799 808
17. Lengyel E, Schmalfeldt B, Konik E, Spathe K, Harting K, Fenn A, et al. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer. Gynecol. Oncol. 2001;82:291-8.
18. S.K. Lutgendorf, D.M. Lamkin, N.B. Jennings, J.M. Arevalo, F. Penedo, K. DeGeest, and et al. Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma Clin. Cancer Res. 14 2008 6839 6846
19. J.E. Brazier, R. Harper, N.M. Jones, A. O'Cathain, K.J. Thomas, T. Usherwood, and et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care BMJ (Clinical Research Ed). 305 1992 160 164
20. D.M. Berwick, J.M. Murphy, P.A. Goldman, J.E. Ware Jr., A.J. Barsky, and M.C. Weinstein Performance of a five-item mental health screening test Med. Care 29 1991 169 176
21. S.S. Tworoger, J.L. Hecht, E. Giovannucci, and S.E. Hankinson Intake of folate and related nutrients in relation to risk of epithelial ovarian cancer Am. J. Epidemiol. 163 2006 1101 1111
22. A. Pan, O.I. Okereke, Q. Sun, G. Logroscino, J.E. Manson, W.C. Willett, and et al. Depression and incident stroke in women Stroke 42 2011 2770 2775
23. A. Pan, M. Lucas, Q. Sun, R.M. van Dam, O.H. Franco, J.E. Manson, and et al. Bidirectional association between depression and type 2 diabetes mellitus in women Arch. Intern. Med. 170 2010 1884 1891
24. A. Pan, Q. Sun, S. Czernichow, M. Kivimaki, O.I. Okereke, M. Lucas, and et al. Bidirectional association between depression and obesity in middle-aged and older women Int. J. Obes. (Lond) 36 2012 595 602
25. R.L. Prentice, J.D. Kalbfleisch, A.V. Peterson Jr., N. Flournoy, V.T. Farewell, and N.E. Breslow The analysis of failure times in the presence of competing risks Biometrics 34 1978 541 554
26. R.C. Kessler, P. Berglund, O. Demler, R. Jin, D. Koretz, K.R. Merikangas, and et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA 289 2003 3095 3105
27. J.C. Coyne, A.V. Ranchor, and S.C. Palmer Meta-analysis of stress-related factors in cancer Nat. Rev. Clin. Oncol. 7 2010
28. Y. Chida, M. Hamer, J. Wardle, and A. Steptoe Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat. Clin. Pract. Oncol. 5 2008 466 475
29. M.E. Oerlemans, M. van den Akker, A.G. Schuurman, E. Kellen, and F. Buntinx A meta-analysis on depression and subsequent cancer risk Clin Pract Epidemiol Ment Health. 3 2007 29
30. E.M. Reiche, S.O. Nunes, and H.K. Morimoto Stress, depression, the immune system, and cancer Lancet Oncol. 5 2004 617 625
31. J. Walburn, K. Vedhara, M. Hankins, L. Rixon, and J. Weinman Psychological stress and wound healing in humans: a systematic review and meta-analysis J. Psychosom. Res. 67 2009 253 271
32. J.T. Casagrande, E.W. Louie, M.C. Pike, S. Roy, R.K. Ross, and B.E. Henderson "Incessant ovulation" and ovarian cancer Lancet 2 1979 170 173
33. L.J. Schouten, C. Rivera, D.J. Hunter, D. Spiegelman, H.O. Adami, A. Arslan, and et al. Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies Cancer Epidemiol. Biomarkers Prev. 17 2008 902 912
34. E.M. Poole, I.M. Lee, P.M. Ridker, J.E. Buring, S.E. Hankinson, and S.S. Tworoger A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor alpha receptor 2 levels and risk of ovarian cancer Am. J. Epidemiol. 178 2013 1256 1264
35. N.I. Gavin, B.N. Gaynes, K.N. Lohr, S. Meltzer-Brody, G. Gartlehner, and T. Swinson Perinatal depression: a systematic review of prevalence and incidence Obstet. Gynecol. 106 2005 1071 1083
36. H.W. Koenigsberg, M.H. Teicher, V. Mitropoulou, C. Navalta, A.S. New, R. Trestman, and et al. 24-h monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression J. Psychiatr. Res. 38 2004 503 511
37. A. Roy, D. Pickar, J. De Jong, F. Karoum, and M. Linnoila Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamic-pituitary-adrenal axis function in depression Arch. Gen. Psychiatry 45 1988 849 857
38. C.L. Raison, R.E. Rutherford, B.J. Woolwine, C. Shuo, P. Schettler, D.F. Drake, and et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers JAMA Psychiatry. 70 2013 31 41
39. D. Spiegel, and J. Giese-Davis Depression and cancer: mechanisms and disease progression Biol. Psychiatry 54 2003 269 282
40. A.J. Mitchell, A. Vaze, and S. Rao Clinical diagnosis of depression in primary care: a meta-analysis Lancet 374 2009 609 619